Cormorant Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Sell |
|
|||||
|
2025
Q1 | $32.5M | Sell |
|
|||||
|
2024
Q4 | $42.9M | Hold |
|
|||||
|
2024
Q3 | $41M | Buy |
|
|||||
|
2024
Q2 | $14.6M | Buy |
|
|||||
|
2024
Q1 | $6.35M | Hold |
|
|||||
|
2023
Q4 | $4.47M | Hold |
|
|||||
|
2023
Q3 | $3.63M | Hold |
|
|||||
|
2023
Q2 | $3.48M | Hold |
|
|||||
|
2023
Q1 | $2.16M | Hold |
|
|||||
|
2022
Q4 | $1.74M | Sell |
|
|||||
|
2022
Q3 | $7.93M | Sell |
|
|||||
|
2022
Q2 | $14.3M | Buy |
|
|||||
|
2022
Q1 | $22.3M | Hold |
|
|||||
|
2021
Q4 | $28M | Buy |
|
|||||
|
2021
Q3 | $28.7M | Buy |
|
|||||
|
2021
Q2 | $31.1M | Buy |
|